Oberweis Asset Management’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-9,050
Closed -$2.58M 222
2023
Q2
$2.58M Buy
9,050
+2,200
+32% +$611K 0.31% 117
2023
Q1
$1.49M Buy
6,850
+1,700
+33% +$331K 0.23% 135
2022
Q4
$1.06M Buy
5,150
+2,350
+84% +$594K 0.23% 129
2022
Q3
$779K Buy
2,800
+1,650
+143% +$420K 0.18% 130
2022
Q2
$220K Buy
+1,150
New +$203K 0.06% 150

Other funds holding SWAV

Oberweis Asset Management's SWAV Position: Q3 2023 in Review

Oberweis Asset Management sold out of Shockwave Medical, Inc. Common Stock (SWAV) in Q3 2023, closing a stake of 9,050 shares — an estimated $2.58M sold.

Oberweis Asset Management first reported a position in SWAV in Q2 2022 and held it in 5 quarters. The position peaked at $2.58M in Q2 2023. 412 funds tracked by Wall St. Rank hold SWAV as of Q3 2023.

  • Oberweis Asset Management reported no remaining Shockwave Medical, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Oberweis Asset Management sold 9,050 Shockwave Medical, Inc. Common Stock shares in Q3 2023, an estimated $2.58M.
  • Oberweis Asset Management first reported a position in Shockwave Medical, Inc. Common Stock in Q2 2022 and held it in 5 quarters.
  • Oberweis Asset Management's Shockwave Medical, Inc. Common Stock position peaked at $2.58M in Q2 2023.
  • 412 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q3 2023.

Based on Oberweis Asset Management's 13F filing for Q3 2023, filed 14 Nov 2023.